Submit a Comment

Lenvima Seated Next to Nexavar in First-Line Hepatocellular Carcinoma

  1. Ferlay J, Soerjomataram I, Dikshit R et al., “Cancer incidence and mortality worldwide: sources, methods, and major patterns in GLOBOCAN 2012.”  Int J Cancer, 36 (5): 359-386, 2014.
  2. Llovet J, Ricci S, Mazzaferro V, et al.; “Sorafenib in advanced hepatocellular carcinoma;” N Engl J Med, 359 (4): 378-390, 2008.
  3. Cheng A, Finn R, Qin S, et al., “Phase III trial of lenvatinib vs sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma,” Abstract 4001, ASCO 2017.
  4. Kantar Health, CancerMPact® Treatment Architecture.  Accessed June 4, 2017.
 

Post a Comment

Your email is never shared. Required fields are marked *